BioSpace News Archive

Biopharmaceutical contract development and manufacturing organization Scorpion Biological Services announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates, which will support the construction of a new biodefense-focused large molecule and biologics biomanufacturing facility in Manhattan, Kansas.

PureTech Health plc announced its results for the year ended December 31, 2021 as well as its cash balance as of the first quarter ended March 31, 2022.

DexCom, Inc. will showcase for the first time its new global portfolio of real-time continuous glucose monitoring systems at the 15th International Conference on Advanced Technologies and Treatments for Diabetes held April 27-30, 2022 in Barcelona.

Midatech Pharma PLC announces its audited preliminary results for the year ended 31 December 2021.

Active Biotech announced that the European Patent Office has issued a decision to grant Active Biotech’s patent related to use of laquinimod as treatment of eye diseases associated with excessive vascularization.

Sosei Group Corporation announces a strategic collaboration with Weatherden, a pioneering clinical development consulting group.

SonoScape Medical Corp. today announced the release of S-Fetus 4.0, the latest software upgrade of the company’s flagship ultrasound product offering.

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the appointment of Darin Leigh as Chief Commercial Officer.

ViGeneron GmbH announced a follow-on collaboration with Daiichi Sankyo Company, Limited to utilize ViGeneron’s novel engineered recombinant adeno-associated virus vectors to address an undisclosed target for the treatment of prevalent eye diseases.

AI Medical Service Inc. has announced 8 billion JPY ( US$70 million ) of financing led by SoftBank Vision Fund 2 (SVF2),